Accelerate diagnostics announces launch of accelerate arc™ module and bc kit

The accelerate arc system cuts hours of wait time and numerous manual steps to deliver identification (id) results unlocks rapid microbial id from positive blood cultures for the large installed base of maldi system users tucson, ariz. , march 28, 2022 /prnewswire/ -- accelerate diagnostics, inc. (nasdaq: axdx) an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, today announced the launch of the accelerate arc system, comprised of the arc module and bc kit, an automated path to rapid and accurate microbial identification for positive blood cultures.
AXDX Ratings Summary
AXDX Quant Ranking